TL
ABBV icon

Tradewinds LLC’s AbbVie ABBV Stock Holding History

Tradewinds LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Sell
2,930
-8,219
-74% -$1.77M 0.72% 38
2026
Q1 		$2.3M Buy
11,149
+1
+0% +$222 0.74% 29
2025
Q4 		$2.55M Sell
11,148
-110
-1% -$25.1K 0.61% 39
2025
Q3 		$2.61M Buy
+11,258
New +$2.29M 0.63% 37
2025
Q2 		– Sell
-11,714
Closed -$2.45M – 83
2025
Q1 		$2.45M Buy
11,714
+490
+4% +$95.3K 0.69% 38
2024
Q4 		$2.15M Buy
11,224
+197
+2% +$36.2K 0.6% 37
2024
Q3 		$2.18M Buy
11,027
+22
+0.2% +$4.11K 0.67% 38
2024
Q2 		$1.89M Buy
11,005
+3,927
+55% +$651K 0.58% 45
2024
Q1 		$1.29M Buy
+7,078
New +$1.22M 0.62% 17
2023
Q3 		$1.06M Sell
7,078
-105
-1% -$15.4K 0.62% 35
2023
Q2 		$968K Hold
7,183
– – 0.57% 36
2023
Q1 		$1.14M Buy
+7,183
New +$1.1M 0.69% 35
2022
Q4 		– Sell
-7,063
Closed -$948K – 120
2022
Q3 		$948K Buy
7,063
+287
+4% +$41.2K 0.69% 34
2022
Q2 		$1.04M Buy
+6,776
New +$1.04M 0.71% 31
2021
Q4 		$1.1M Buy
+7,078
New +$836K 1.29% 13

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tradewinds LLC's ABBV Position: Q2 2026 in Review

Tradewinds LLC reduced its AbbVie (ABBV) stake by 74% in Q2 2026, selling an estimated $1.77M and leaving 2,930 shares worth $3.22M. The position accounts for 0.72% of the portfolio, ranked #38.

Tradewinds LLC first reported a position in ABBV in Q4 2021 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tradewinds LLC held 2,930 shares of AbbVie worth $3.22M as of Q2 2026.
  • Tradewinds LLC sold 8,219 AbbVie shares in Q2 2026, an estimated $1.77M.
  • AbbVie made up 0.72% of Tradewinds LLC's portfolio in Q2 2026, its #38 holding.
  • Tradewinds LLC first reported a position in AbbVie in Q4 2021 and has held it in 15 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tradewinds LLC's 13F filing for Q2 2026, filed 14 Aug 2026.